Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Diclofenac Capsules to Treat Pain Following Bunionectomy

ClinicalTrials.gov ID: NCT01462435

Public ClinicalTrials.gov record NCT01462435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Diclofenac [Test] Capsules for the Treatment of Acute Postoperative Pain After Bunionectomy

Study identification

NCT ID
NCT01462435
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Iroko Pharmaceuticals, LLC
Industry
Enrollment
428 participants

Conditions and interventions

Interventions

  • Diclofenac Test (lower dose) Drug
  • Diclofenac Test (upper dose) Drug
  • Celecoxib Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2011
Primary completion
Jan 31, 2012
Completion
Jul 31, 2012
Last update posted
Feb 3, 2014

2011 – 2012

United States locations

U.S. sites
4
U.S. states
4
U.S. cities
4
Facility City State ZIP Site status
Premier Research Group Limited Phoenix Arizona 85027
Chesapeake Research Group, LLC Pasadena Maryland 21122
Premier Research Group Limited Austin Texas 78705
Premier Research Group Limited Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01462435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 3, 2014 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01462435 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →